John-Patrick Mulligan

University College Hospital at Westmoreland Street

Papers

2

Total Citations

34

H-Index

2

About

John-Patrick Mulligan is a urologic researcher whose work centers on improving the precision of prostate cancer staging through advanced imaging. His primary research area is the application of multi-parametric MRI (mpMRI) to pre-operatively predict extra-prostatic extension (EPE)—a critical factor in surgical planning for robot-assisted radical prostatectomy. His most influential study, published in 2022, demonstrated that a negative mpMRI effectively rules out EPE on a side-specific basis, challenging prior debates about MRI accuracy. Using a risk-stratified 5-point Likert scale, Mulligan’s team provided robust evidence that mpMRI can reliably guide nerve-sparing decisions, reducing unnecessary resections. This work has garnered over 30 citations, reflecting its immediate impact on clinical practice. By clarifying the role of imaging in staging, Mulligan has helped bridge the gap between radiology and surgical oncology, offering patients more tailored, less invasive treatments. His contributions are particularly valuable for trainees and clinicians seeking evidence-based approaches to prostate cancer management, underscoring the power of imaging to refine surgical outcomes.

Research Focus

Key Achievements

2
H-Index
2
Papers
34
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Negative mpMRI Rules Out Extra-Prostatic Extension in Prostate Cancer before Robot-Assisted Radical Prostatectomy
30 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 30
🏛 Institutions: University College Hospital at Westmoreland Street

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago